• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AVANOS MEDICAL INC. MICROCUFF PEDIATRIC ENDOTRACHEAL TUBE, ORAL/NASAL MAGILL-4.3-3.0-10; VAP MICROCUFF ENDOTRACHEAL TUBES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AVANOS MEDICAL INC. MICROCUFF PEDIATRIC ENDOTRACHEAL TUBE, ORAL/NASAL MAGILL-4.3-3.0-10; VAP MICROCUFF ENDOTRACHEAL TUBES Back to Search Results
Model Number 35111
Medical Device Problem Code Partial Blockage (1065)
Health Effect - Clinical Code No Code Available (3191)
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(4): no code available: reintubated.A review of the device history record is not possible as no lot number was provided.The sample is reported to be available, but has not yet been received by the manufacturer.Avanos medical inc.Has no independent knowledge of the event reported but is relaying the information that was provided by the user facility where the incident occurred.This product incident is documented in the avanos medical inc.Complaint database and identified as complaint (b)(4).This information is submitted pursuant to 21cfr803, in compliance with the medical device reporting requirement and should not be considered to be an admission that an avanos medical inc.Product is defective or caused serious injury.
 
Event or Problem Description
It was reported that "blood adhered to the distal end of the tube and the tube was occluded.Intubating a patient was needed again." no patient injury reported.Additional information has been requested but not yet received.
 
Additional Manufacturer Narrative
Additional information: b5, b7, d10.The product involved in the report has been returned and is being processed for evaluation.The investigation remains in progress.All information reasonably known as of 15 jan 2021 has been included in this health authority report.Should additional information be obtained, a follow-up health authority report will be provided.The information provided by avanos medical inc.Represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to avanos medical inc.Avanos medical inc.Has no independent knowledge of the event reported but is relaying the information that was provided by the user facility where the incident occurred.This product incident is documented in the avanos medical inc.Complaint database and identified as complaint (b)(4).This information is submitted pursuant to 21cfr803, in compliance with the medical device reporting requirement and should not be considered to be an admission that an avanos medical inc.Product is defective or caused serious injury.
 
Event or Problem Description
Additional information received 25-dec-2020 indicated the device was used by oral intubation.The tube was clogged and the patient had to be extubated and re-intubated by using a new device of the same model.
 
Additional Manufacturer Narrative
The actual complaint product was not returned for evaluation.The sample was received without the original packaging; no lot number information was retrieved.There was no visible build-up inside the et tube or vent connector.The vent connector appeared to have openings.The balloon cuff and pilot balloon did not appear clogged or blocked.The reported event could not be confirmed.No root cause could be identified.All information reasonably known as of 24 mar 2021 has been included in this health authority report.Should additional information be obtained, a follow-up health authority report will be provided.The information provided by avanos medical inc.Represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to avanos medical inc.Avanos medical inc.Has no independent knowledge of the event reported but is relaying the information that was provided by the user facility where the incident occurred.This product incident is documented in the avanos medical inc.Complaint database and identified as complaint (b)(4).This information is submitted pursuant to 21cfr803, in compliance with the medical device reporting requirement and should not be considered to be an admission that an avanos medical inc.Product is defective or caused serious injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MICROCUFF PEDIATRIC ENDOTRACHEAL TUBE, ORAL/NASAL MAGILL-4.3-3.0-10
Common Device Name
VAP MICROCUFF ENDOTRACHEAL TUBES
Manufacturer (Section D)
AVANOS MEDICAL INC.
5405 windward parkway
alpharetta GA 30004
MDR Report Key11056695
Report Number3011270181-2020-00135
Device Sequence Number14116319
Product Code BTR
UDI-Device Identifier10680651351118
UDI-Public10680651351118
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K080821
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source company representative,distri
Initial Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date (Section B) 03/26/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number35111
Device Catalogue NumberN/A
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/08/2021
Was the Report Sent to FDA? No
Initial Date Received by Manufacturer 12/08/2020
Supplement Date Received by Manufacturer12/25/2020
03/04/2021
Initial Report FDA Received Date12/22/2020
Supplement Report FDA Received Date01/15/2021
03/27/2021
Patient Sequence Number1
-
-